Yew Bio Pharm Revenue, Profits - YEWB Quarterly Income Statement

Add to My Stocks
$0.3 $0 (0%) YEWB stock closing price Jul 19, 2018 (Closing)

YEWB stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Yew Bio Pharm stock price. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from 5.5M to 3.03M and how operating and non operating activities have impacted the YEWB stock. One also needs to look at Yew Bio Pharm assets, operating expenses and Yew Bio Pharm free cash flow. The Yew Bio Pharm profit and loss statement shows revenue of $3.03M for 2018 Q1. Revenue has decreased by -44.91% QoQ for YEWB stock.

View and download details of revenue and profits for Yew Bio Pharm for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Yew Bio Pharm Revenues or Net Sales
3.03M5.5M11.57M15.6M7.88M12M14.67M16.06M8.62M17.27M
Cost Of Goods Sold (COGS)2.55M12.3M10.81M5.01M7.35M13.24M13.24M14.41M7.22M15.52M
Yew Bio Pharm Gross Profit
--6.77M-10.58M--1.21M1.41M1.64M1.39M1.78M
Research & Development Expense----------
Selling General & Admin Expense----------
Income Before Depreciation Depletion Amortization--7.66M-10.28M--1.36M1.11M1.3M1.07M1.32M
Depreciation Depletion Amortization----------
Non Operating Income-0.07M-0.15M--0.03M-0.05M-0.04M-0.03M--0.02M-
Interest Expense----------
Yew Bio Pharm Pretax Income
--7.81M-10.25M--1.41M1.08M1.3M1.05M1.38M
Provision for Income Taxes----------0.04M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations--7.83M-10.26M--1.43M1.08M1.31M1.05M1.39M
Extraordinary Items & Discontinued Operations----------
Yew Bio Pharm Profit/ Loss (Net Income)
--7.83M-10.26M--1.43M1.08M1.31M1.05M1.39M
Average Shares used to compute Diluted EPS60.09M53.98M54.56M53.04M56.67M51.88M51.89M51.88M51.88M51.88M
Average Shares used to compute Basic EPS51.88M53.98M51.88M51.88M51.88M51.88M51.88M51.88M51.88M51.88M
Income Before Nonrecurring Items--7.83M-10.26M--1.43M1.08M1.31M1.05M1.39M
Income from Nonrecurring Items----------
Yew Bio Pharm Earnings Per Share Basic Net
0.00-0.150.010.200.00-0.030.020.030.020.03
Yew Bio Pharm Earnings Per Share Diluted Net
0.00-0.150.010.190.00-0.030.020.030.020.03
EPS Diluted Before Nonrecurring Items0.00-0.150.010.190.00-0.030.020.030.020.03
Preferred Dividends Acc Pd----------
Dividends Common0.000.00--------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Yew Bio Pharm stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $3.03M for this quarter of 2018 Q1. Our Yew Bio Pharm revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $- for Yew Bio Pharm for 2018 Q1. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called the profit and loss statement. Apart from the YEWB income statement, one can check the Yew Bio Pharm historical stock prices to check how the price has moved with time.

Yew Bio Pharm Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
5.66
PS Ratio (price sales ratio)
0.44
Operating Margin
6.9
Net Profit Margin
5
Dividend Yield
0%